Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

GlycoDesign and NRC establish infectious disease research program

Dec. 29, 2000

EU recommends approval of PegIntron/Rebetol combination for hepatitis C treatment

Dec. 27, 2000

Potential of tegaserod in GERD therapy indicated by recent clinical study findings

Dec. 22, 2000

Kyowa Hakko discusses work leading to development of therapeutically active 5-HT4 agonists

Dec. 21, 2000

Nucleoside analogue MIV-210 enters phase I for HBV treatment

Dec. 21, 2000

Phase I trials commence for Idun caspase inhibitor

Dec. 20, 2000

SB granted rights to new GERD therapy in all markets outside Korea

Dec. 20, 2000

Cangene's newest hyperimmune agent targets hepatitis C

Dec. 19, 2000

Schering-Plough seeks additional FDA approval for Rebetol capsules

Dec. 18, 2000

Gilead cleared to test adefovir dipivoxil for HBV in the clinic in China

Dec. 15, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...